Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2004.
The usual cause for the fund is to invest in rounds with 9 partakers. Despite the Lotus, startups are often financed by Novartis Venture Fund, Alta Partners, Lombard Odier. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, JAFCO Japan, HBM Partners. In the next rounds fund is usually obtained by Novartis Venture Fund, JAFCO Japan, HBM Partners.
This organization was formed by Mitchell Kapor.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Therapeutics, Biopharma. Among the most popular portfolio startups of the fund, we may highlight AGY Therapeutics, AGY Therapeutics.
Related Funds
| Fund Name | Location |
| Aceon Venture | China, Fujian, Xiamen |
| Asia Capital | Colombo, Sri Lanka, Western Province |
| aws Mittelstandsfonds | Austria, Vienna |
| Baichuan Huida Touzi | China, Guangdong, Tianjin |
| CanQbate | - |
| Capital Medica Ventures | Chiyoda, Japan |
| Co-Share capital | China, Guangdong, Guangzhou |
| Draper Richards | California, Menlo Park, United States |
| Falcon Capital | England, London, United Kingdom |
| HPE Growth | Amsterdam, Netherlands, North Holland |
| Jabil | Florida, St. Petersburg, United States |
| Kendryx Enterprises | Breckenridge, Colorado, United States |
| Money Forward | Chiyoda, Japan |
| New Science Ventures | New York, New York, United States |
| Niji | France, Ile-de-France, Issy-les-moulineaux |
| NVEST VENTURE | Bangkok, Krung Thep, Thailand |
| Promus Capital | Chicago, Illinois, United States |
| Stream Global | Central, Central Region, Singapore |
| SVASE Cambridge West Ventures | California, Redwood City, United States |
| Xuwei Investment | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AGY Therapeutics | $9M | 07 Aug 2004 | San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AGY Therapeutics | $9M | 07 Aug 2004 | San Francisco, California, United States |
